Multiple early factors anticipate post-acute COVID-19 sequelae

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 01, 2022
Source ID
10.1016/j.cell.2022.01.014

Entities

People

  • Ana Jimena Pavlovitch-Bedzyk
  • Andrew T Magis
  • Antoni Ribas
  • Brett Smith
  • Caroline J. Duncombe
  • Chengzhen L. Dai
  • Christopher Lausted
  • Christos J. Petropoulos
  • Clifford C Rostomily
  • Damon H May
  • Dan Yuan
  • Daniel Chen
  • Dave S.b. Hoon
  • Denise J. McCulloch
  • Fan Yang
  • Gladys Wojciechowska
  • Heather A. Algren
  • Helen Chu
  • Hunter R. Cole
  • Inyoul Lee
  • James R. Heath
  • Jason D Goldman
  • Jeffrey A. Bluestone
  • Jennifer J. Hadlock
  • Jing Zhou
  • Jingyi Xie
  • Jongchan Choi
  • Joshua A Hill
  • Julie A. Wallick
  • Kai Wang
  • Kelsey Scherler
  • Kim Murray
  • Kristin G Anderson
  • Lee Rowen
  • Leroy Hood
  • Lesley Jones
  • Lewis L. Lanier
  • Li Jing
  • Mark Klinger
  • Mark M. Davis
  • Mary E. Micikas
  • Naeha Subramanian
  • Nathan D Price
  • Pamela Troisch
  • Philip D. Greenberg
  • Priyanka Baloni
  • Quinn Degottardi
  • Rachel Liu
  • Rachel M. Gittelman
  • Rachel Ng
  • Raphael Gottardo
  • Rebecca A. Cochran
  • Rick Edmark
  • Rongyu Zhang
  • Ruth Taniguchi
  • Ryan Roper
  • Sarah Li
  • Scott D Boyd
  • Sean Mackay
  • Sergey A Kornilov
  • Shannon Fallen
  • Shen Dong
  • Simon Evans
  • Sunga Hong
  • Terri Wrin
  • Thomas M. Snyder
  • Trevan D Fischer
  • Venkata R. Duvvuri
  • Wei Wei
  • William Chour
  • William R. Berrington
  • Yapeng Su
  • Yong Zhou

Organizations

  • Biomedical Advanced Research and Development Authority
  • Gates Foundation
  • Istituto Superiore di Sanità
  • Parker Institute for Cancer Immunotherapy
  • United States Department of Defense